netFormulary East Kent Hospitals University NHS
NHS Foundation Trust  
 Search
 Formulary Chapter 8: Malignant disease and immunosuppression - Full Chapter
Notes:

Foundation year 1 prescribing guidance. No F1 doctor should prescribe a  cytotoxic- please refer to the following http://kchspprd03/_layouts/15/osssearchresults.aspx?u=http%3A%2F%2Fkchspprd03&k=foundation%20year%201%20prescribing

Kent and Medway Oncological Treatment Pathway relevant to a condition. This section of the formulary will be explicit as to which treatments are funded routinely by the NHS for an oncology indication but a patient's treatment order will reflect the more detailed information in the respective pathway. 

Chapter Links...
 Details...
08.01.05  Expand sub section  Other antineoplastic drugs
 note 


Warning  No F1 (First year foundation programme) doctor may prescribe a cytotoxic drug in the Trust. See Advice on Foundation Year 1 (FY1) Prescribing All other doctors may only prescribe having competency for that cytotoxic drug and route in that indication.

08.01.05  Expand sub section  Amsacrine
08.01.05  Expand sub section  Arsenic trioxide
Cytotoxic Drug Arsenic Trioxide (Trisenox)
View adult BNF View SPC online View childrens BNF
Formulary
Red
  • Relapsed or refractory acute promyelocytic leukaemia (APML)
    Warning - Very high risk drug for QT prolongation - please check this list for interaction potential 
  •    
    08.01.05  Expand sub section  Bevacizumab
    08.01.05  Expand sub section  Bexarotene to top
    08.01.05  Expand sub section  Bortezomib
    08.01.05  Expand sub section  Cetuximab
    08.01.05  Expand sub section  Crisantaspase
    08.01.05  Expand sub section  Dacarbazine and Temozolomide
    08.01.05  Expand sub section  Hydroxycarbamide to top
    08.01.05  Expand sub section  Mitotane
    08.01.05  Expand sub section  Pentostatin
    08.01.05  Expand sub section  Platinum compounds
    08.01.05  Expand sub section  Porfimer sodium and temoporfin
    08.01.05  Expand sub section  Procarbazine to top
    08.01.05  Expand sub section  Protein kinase inhibitors
    08.01.05  Expand sub section  Taxanes
    08.01.05  Expand sub section  Topoisomerase I inhibitors
    08.01.05  Expand sub section  Trabectedin
    08.01.05  Expand sub section  Trastuzumab to top
    08.01.05  Expand sub section  Tretinoin
    08.01.05  Expand sub section  Vismodegib
     ....
    Key
    note Notes
    Section Title Section Title (top level)
    Section Title Section Title (sub level)
    First Choice Item First Choice item
    Non Formulary Item Non Formulary section
    Restricted Drug
    Restricted Drug
    Unlicensed Drug
    Unlicensed
    Track Changes
    Display tracking information
    click to search medicines.org.uk
    Link to adult BNF
    click to search medicines.org.uk
    Link to children's BNF
    click to search medicines.org.uk
    Link to SPCs
    Cytotoxic Drug
    Cytotoxic Drug
    CD
    Controlled Drug
    High Cost Medicine
    High Cost Medicine
    Cancer Drugs Fund
    Cancer Drugs Fund
    NHSE
    NHS England
    Homecare
    Homecare
    CCG
    CCG

    Traffic Light Status Information

    Status Description

    Amber

    Requires to be initiated by specialist for repeat GP Prescribing (Purple as per Eclipse East Kent Primary Care Formulary, may be top sliced) If a downloadable EKPG Prescribing Information Sheet exists in the formulary entry for the drug, it, or an URL (shortcut to webpage/document) should be sent to the GP. See also "Hints in how to incorporate documents for medicines information into clinical communications to GPs".  

    Amber 1

    Shared Care (Orange as per Eclipse East Kent Primary Care Formulary). See the Principles of Shared Care Agreements and Shared Care Agreements: Assessment against agreed Principles of Shared Care documents. If a downloadable template document exists in the formulary entry for this drug, it should be sent to the GP (and patient) once patient specific details are incorporated. See "Hints in how to incorporate shared care documents for medicines into clinical communications to GPs".  

    Amber 2

    Shared Care and topsliced (Orange as per Eclipse East Kent Primary Care Formulary) See the Principles of Shared Care Agreements and Shared Care Agreements: Assessment against agreed Principles of Shared Care documents. If a downloadable template document exists in the formulary entry for this drug, it should be sent to the GP (and patient) once patient specific details are incorporated. See "Hints in how to incorporate shared care documents for medicines into clinical communications to GPs".  

    Black

    A decision has been made by either or both the local or national NHS not to routinely commission this preparation for its licensed indications  

    Blue

    No comment on drug in East Kent Primary Care Formulary (Blue as per Eclipse East Kent Primary Care Formulary)  

    Brown

    Exceptional Use Only (Brown as per Eclipse East Kent Primary Care Formulary)   

    Green

    On East Kent Primary Care Formulary (Pink or Green as per Eclipse East Kent Primary Care Formulary)  

    Grey

    Not assessed/Not recommended (As per Eclipse East Kent Primary Care Formulary)  

    Red

    Hospital Only (As per Eclipse East Kent Primary Care Formulary)  

    RedRed

    Known to be commissioned for local NHS patients but only available to them from another provider than EKHUFT  

    netFormulary